Trastuzumab,Tucatinib
Seagen,Roche
[]
great day for gi and colorectal cancer! fda grants accelerated approval to tucatinib with trastuzumab for her2+ colorectal cancer #gi23 #colorectalcancer
GI #Oncologist @ClevelandClinic | @USNews contributor | Tweets my own